Boston Cambridge Biotech Networks

Advertise With Biotech Networks
  • Home
  • About
  • News
    • All News
    • BCBN Trending News
  • Jobs
    • All Jobs
    • Post a Job
  • Subscribe
  • Contact
News Ticker
  • [ December 6, 2023 ] AbbVie makes another local multibillion-dollar buy with Cerevel acquisition News
  • [ December 6, 2023 ] Operations Product Leader III – Thermo Fisher Scientific – Cambridge, MA Jobs
  • [ December 6, 2023 ] Principal Scientist, Cell Culture MS&T – Bristol Myers Squibb – Devens, MA Jobs
  • [ December 6, 2023 ] Principal Associate Scientist – RNA – Ginkgo Bioworks Inc. – Boston, MA Jobs
  • [ December 6, 2023 ] Healey administration pursues new blueprint for a dominant AI sector: ‘AI for X’ News
HomeNewsJounce pivots, agrees to $96.5M acquisition by mysterious biotech

Jounce pivots, agrees to $96.5M acquisition by mysterious biotech

March 27, 2023 BCBN News Comments Off on Jounce pivots, agrees to $96.5M acquisition by mysterious biotech

Jounce Therapeutics Inc. has abandoned plans to merge with a U.K. firm, instead agreeing to be acquired for some $96.5 million by a company called Concentra Biosciences, LLC.
Click here to view original post

Advertise With Biotech Networks
Previous

Struggling MD Anderson spinout files for bankruptcy protection

Next

CSL Opens New, State-of-the-Art Vaccine Research and Development Facility in Waltham, Massachusetts

Search Jobs

POST A JOB

BCBN Featured Jobs

Tweets by BCBNJobs

Copyright © 2023 Biotech Networks, LLC

Get Biotech Networks Briefs in Your Inbox: Trending News & Featured Jobs